Amarin Corp PLC (AMRN)
0.91
-0.01
(-0.87%)
USD |
NASDAQ |
May 03, 16:00
0.9073
0.00 (0.00%)
After-Hours: 20:00
Amarin Cash from Operations (Quarterly): -0.645M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.645M |
September 30, 2023 | 7.329M |
June 30, 2023 | 7.204M |
March 31, 2023 | -7.008M |
December 31, 2022 | 1.552M |
September 30, 2022 | -18.21M |
June 30, 2022 | -64.58M |
March 31, 2022 | -98.85M |
December 31, 2021 | -28.24M |
September 30, 2021 | -4.54M |
June 30, 2021 | -15.05M |
March 31, 2021 | -18.70M |
December 31, 2020 | -38.32M |
September 30, 2020 | 10.85M |
June 30, 2020 | 1.587M |
March 31, 2020 | 4.137M |
December 31, 2019 | -8.936M |
September 30, 2019 | 21.75M |
June 30, 2019 | 15.91M |
March 31, 2019 | -38.09M |
December 31, 2018 | -32.30M |
September 30, 2018 | -28.16M |
June 30, 2018 | -24.44M |
March 31, 2018 | -9.805M |
December 31, 2017 | -2.14M |
Date | Value |
---|---|
September 30, 2017 | -6.277M |
June 30, 2017 | -10.50M |
March 31, 2017 | -13.92M |
December 31, 2016 | -19.31M |
September 30, 2016 | -18.72M |
June 30, 2016 | -8.875M |
March 31, 2016 | -24.90M |
December 31, 2015 | -23.21M |
September 30, 2015 | -22.55M |
June 30, 2015 | -25.62M |
March 31, 2015 | -12.64M |
December 31, 2014 | -15.92M |
September 30, 2014 | -19.88M |
June 30, 2014 | -11.31M |
March 31, 2014 | -27.49M |
December 31, 2013 | -33.08M |
September 30, 2013 | -44.84M |
June 30, 2013 | -52.78M |
March 31, 2013 | -59.64M |
December 31, 2012 | -43.76M |
September 30, 2012 | -39.42M |
June 30, 2012 | -21.38M |
March 31, 2012 | -17.74M |
December 31, 2011 | -11.58M |
September 30, 2011 | -8.277M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-98.85M
Minimum
Mar 2022
21.75M
Maximum
Sep 2019
-12.25M
Average
-4.54M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
Trinity Biotech PLC | 0.242M |
DBV Technologies SA | -13.69M |
Adaptimmune Therapeutics PLC | -14.68M |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | -- |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -71.00M |
Cash from Financing (Quarterly) | 0.083M |
Free Cash Flow | 6.347M |
Free Cash Flow Per Share (Quarterly) | -0.0028 |
Free Cash Flow to Equity (Quarterly) | -1.154M |
Free Cash Flow to Firm (Quarterly) | -1.154M |
Free Cash Flow Yield | 1.71% |